Moreover, the data obtained in this study suggest that IL-1 activation is tightly controlled at the tissue level in SLE, and a failure of inhibitory circuits may be critical in triggering the active stages of the disease. This evidence concerns the gene IL1A and systemic lupus erythematosus.